Ironically, she had volunteered to test the safety of combrestatin, but was refused a higher dose of the drug because its safety has yet to be scientifically proved. Datta is still in trouble with cancer. Another treatment with a chemotherapy agent called navelbine has begun to show evidence of stabilizing her tumors, and she continues to watch for promising experimental treatments, hoping she can keep her cancer at bay until science and its rigid demands for proof catch up. Twigg, on the other hand, is elated. Defy the prognosis.
Someone has to be first.
For Twigg, it's much too soon to say cure , much too early to know if he's the first of anything at all. One doctor talks of discussions with ethicists about how to respond fairly if early results live up to the best hopes.